Cargando…
The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer
Prostate cancer (PCa) remains the second most common type of cancer in men worldwide in 2020. Despite its low death rate, the need for new therapies or prevention strategies is critical. The prostate carcinogenesis process is complex and multifactorial. PCa is caused by a variety of mutations and ca...
Autores principales: | Sousa, André P., Costa, Raquel, Alves, Marco G., Soares, Raquel, Baylina, Pilar, Fernandes, Rúben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992047/ https://www.ncbi.nlm.nih.gov/pubmed/35399507 http://dx.doi.org/10.3389/fcell.2022.843458 |
Ejemplares similares
-
Metabolic Dysfunction Biomarkers as Predictors of Early Diabetes
por: Luís, Carla, et al.
Publicado: (2021) -
Impact of umbilical cord mesenchymal stromal/stem cell secretome and cord blood serum in prostate cancer progression
por: Sousa, André, et al.
Publicado: (2023) -
Underestimated Prediabetic Biomarkers: Are We Blind to Their Strategy?
por: Luís, Carla, et al.
Publicado: (2022) -
Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients
por: Gonçalves, Ana Cristina, et al.
Publicado: (2021) -
Mitochondria-Associated Endoplasmic Reticulum Membranes in the Pathogenesis of Type 2 Diabetes Mellitus
por: Yang, Shanshan, et al.
Publicado: (2020)